Literature DB >> 34669122

An Alternative Explanation for Alzheimer's Disease and Parkinson's Disease Initiation from Specific Antibiotics, Gut Microbiota Dysbiosis and Neurotoxins.

Kevin Roe1.   

Abstract

The late onset neuropathologies, including Alzheimer's disease and Parkinson's disease, have become increasingly prevalent. Their causation has been linked to genetics, gut microbiota dysbiosis (gut dysbiosis), autoimmune diseases, pathogens and exposures to neurotoxins. An alternative explanatory hypothesis is provided for their pathogenesis. Virtually everyone has pervasive daily exposures to neurotoxins, through inhalation, skin contact, direct blood transmission and through the gastrointestinal tract by ingestion. As a result, every individual has substantial and fluctuating neurotoxin blood levels. Two major barriers to neurotoxin entry into the central nervous system are the blood-brain barrier and the intestinal wall, in the absence of gut dysbiosis. Inflammation from gut dysbiosis, induced by antibiotic usage, can increase the intestinal wall permeability for neurotoxins to reach the bloodstream, and also increase the blood-brain barrier permeability to neurotoxins. Gut dysbiosis, including gut dysbiosis caused by antibiotic treatments, is an especially high risk for neurotoxin entry into the brain to cause late onset neuropathologies. Gut dysbiosis has far-reaching immune system and central nervous system effects, and even a transient gut dysbiosis can act in combination with neurotoxins, such as aluminum, mercury, lead, arsenic, cadmium, selenium, manganese, organophosphate pesticides and organochlorines, to reach neurotoxin blood levels that can initiate a late onset neuropathology, depending on an individual's age and genetic vulnerability.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; Gut dysbiosis; Neurodegenerative disease; Neuropathology; Neurotoxin; Parkinson’s disease

Mesh:

Substances:

Year:  2021        PMID: 34669122     DOI: 10.1007/s11064-021-03467-y

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  19 in total

Review 1.  Is Parkinson's disease a chronic low-grade inflammatory bowel disease?

Authors:  Malvyne Rolli-Derkinderen; Laurène Leclair-Visonneau; Arnaud Bourreille; Emmanuel Coron; Michel Neunlist; Pascal Derkinderen
Journal:  J Neurol       Date:  2019-04-12       Impact factor: 4.849

2.  Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study.

Authors:  Bojing Liu; Fang Fang; Nancy L Pedersen; Annika Tillander; Jonas F Ludvigsson; Anders Ekbom; Per Svenningsson; Honglei Chen; Karin Wirdefeldt
Journal:  Neurology       Date:  2017-04-26       Impact factor: 9.910

Review 3.  Gastrointestinal Dysfunction in Parkinson's Disease.

Authors:  Casper Skjærbæk; Karoline Knudsen; Jacob Horsager; Per Borghammer
Journal:  J Clin Med       Date:  2021-01-31       Impact factor: 4.241

Review 4.  Antibiotics as Major Disruptors of Gut Microbiota.

Authors:  Jaime Ramirez; Francisco Guarner; Luis Bustos Fernandez; Aldo Maruy; Vera Lucia Sdepanian; Henry Cohen
Journal:  Front Cell Infect Microbiol       Date:  2020-11-24       Impact factor: 5.293

Review 5.  The intestinal neuro-immune axis: crosstalk between neurons, immune cells, and microbes.

Authors:  Amanda Jacobson; Daping Yang; Madeleine Vella; Isaac M Chiu
Journal:  Mucosal Immunol       Date:  2021-02-04       Impact factor: 7.313

Review 6.  Aluminum environmental pollution: the silent killer.

Authors:  Reema H Alasfar; Rima J Isaifan
Journal:  Environ Sci Pollut Res Int       Date:  2021-07-01       Impact factor: 4.223

Review 7.  The blood-brain barrier in systemic infection and inflammation.

Authors:  Ian Galea
Journal:  Cell Mol Immunol       Date:  2021-09-30       Impact factor: 11.530

8.  The blood-brain barrier in health and disease: Important unanswered questions.

Authors:  Caterina P Profaci; Roeben N Munji; Robert S Pulido; Richard Daneman
Journal:  J Exp Med       Date:  2020-04-06       Impact factor: 14.307

Review 9.  The progress of gut microbiome research related to brain disorders.

Authors:  Sibo Zhu; Yanfeng Jiang; Kelin Xu; Mei Cui; Weimin Ye; Genming Zhao; Li Jin; Xingdong Chen
Journal:  J Neuroinflammation       Date:  2020-01-17       Impact factor: 8.322

View more
  4 in total

Review 1.  Ergothioneine and central nervous system diseases.

Authors:  Noritaka Nakamichi; Sota Tsuzuku; Fumiya Shibagaki
Journal:  Neurochem Res       Date:  2022-07-05       Impact factor: 4.414

Review 2.  Diet, Gut Microbiome, and Cognitive Decline.

Authors:  Susan Ettinger
Journal:  Curr Nutr Rep       Date:  2022-08-26

Review 3.  Autism Spectrum Disorder Initiation by Inflammation-Facilitated Neurotoxin Transport.

Authors:  Kevin Roe
Journal:  Neurochem Res       Date:  2022-01-20       Impact factor: 3.996

4.  Is the Use of Glyphosate in Modern Agriculture Resulting in Increased Neuropsychiatric Conditions Through Modulation of the Gut-brain-microbiome Axis?

Authors:  Jacqueline A Barnett; Maya L Bandy; Deanna L Gibson
Journal:  Front Nutr       Date:  2022-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.